The CIN pathway is the most frequent; it involves the classic adenoma-carcinoma sequence and genetic alterations in adenomatous polyposis coli—APC—(30–70%) and Kirsten Rat Sarcoma viral antigen homolog—KRAS—(30–50%). This evidence concerns the gene KRAS and carcinoma.